Nektar Therapeutics (NKTR) — Long-term Investment Intensity
Nektar Therapeutics (NKTR) has a Long-term Investment Intensity of 31.1% as of June 2026. Long-term investments of $340.48 Million represent 31.1% of total assets of $1.10 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Nektar Therapeutics (NKTR) asset resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Nektar Therapeutics Long-term Investment Intensity (2011–2025)
This chart shows how Nektar Therapeutics's Long-term Investment Intensity has evolved across 9 annual periods from 2011 to 2025. As of June 2026, the intensity stands at 31.1%, reflecting long-term investments of $340.48 Million against total assets of $1.10 Billion USD. For the complete balance sheet picture, see NKTR total assets.
Annual Long-term Investment Intensity for Nektar Therapeutics (2011–2025)
The table below presents the year-by-year Long-term Investment Intensity for Nektar Therapeutics from 2011 to 2025, covering 9 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read debt load of Nektar Therapeutics for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 1.2% | $3.49 Million | $280.41 Million | ▼ -7.3 pp |
| 2024 | 8.6% | $26.09 Million | $303.85 Million | ▲ +2.1 pp |
| 2023 | 6.5% | $25.82 Million | $398.03 Million | ▲ +0.7 pp |
| 2021 | 5.8% | $64.83 Million | $1.12 Billion | ▼ -3.1 pp |
| 2020 | 8.9% | $136.66 Million | $1.54 Billion | ▼ -5.2 pp |
| 2019 | 14.1% | $279.12 Million | $1.98 Billion | ▼ -13.0 pp |
| 2018 | 27.1% | $582.89 Million | $2.15 Billion | ▲ +15.9 pp |
| 2017 | 11.2% | $57.09 Million | $508.87 Million | ▼ -17.4 pp |
| 2011 | 28.6% | $173.77 Million | $606.55 Million | — |